Akoya Biosciences Inc. (AKYA)

NASDAQ: AKYA · Real-Time Price · USD

1.24

0.03 (2.48%)

At close: May 02, 2025, 3:59 PM

1.22

-1.21%

After-hours: May 02, 2025, 04:05 PM EDT

Akoya Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-55.37M	-63.32M	-70.64M	-42.94M	-16.71M	-14.75M
Depreciation & Amortization	7.65M	8.89M	7.15M	4.79M	3.81M	3.06M
Stock-Based Compensation	9.31M	10.44M	7.43M	4.04M	477K	153K
Other Working Capital	-3.31M	-2.03M	6.63M	-1.32M	-574K	6.05M
Other Non-Cash Items	8.18M	7.63M	367K	2.75M	3.17M	-1.01M
Deferred Income Tax	4K	-51K	35K	-155K	7K	156K
Change in Working Capital	-13.88M	-14.48M	2.16M	-4.56M	2.39M	-1.38M
Operating Cash Flow	-44.1M	-50.9M	-53.5M	-36.07M	-6.84M	-13.78M
Capital Expenditures	-2.46M	-3.65M	-7.36M	-5.09M	-3.29M	-2.87M
Cash Acquisitions	n/a	n/a	55K	n/a	145K	n/a
Purchase of Investments	-104.29M	n/a	-40.77M	n/a	-145K	-10M
Sales Maturities Of Investments	82.7M	7M	34M	n/a	10.17M	n/a
Other Investing Acitivies	n/a	n/a	-6.72M	n/a	-145K	-23K
Investing Cash Flow	-24.05M	3.35M	-14.08M	-5.09M	6.73M	-12.89M
Debt Repayment	-1.02M	10.57M	30.63M	-322K	9.79M	4.96M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	-1.44M	n/a	n/a
Other Financial Acitivies	-2.18M	-1.7M	-1.9M	239K	-4.3M	23.6M
Financial Cash Flow	-3.21M	56.84M	28.73M	137.03M	5.49M	28.56M
Net Cash Flow	-71.36M	9.29M	-38.85M	95.87M	5.37M	1.89M
Free Cash Flow	-46.56M	-54.55M	-60.86M	-41.16M	-10.14M	-16.64M